识别和表征肿瘤-免疫相互作用的数学模型中兴奋性的影响
Identifying and characterising the impact of excitability in a mathematical model of tumour-immune interactions
摘要:
我们研究了最初由Kuznetsov等人(1994)提出的五室数学模型,以研究肿瘤微环境中肿瘤和免疫细胞之间的非线性相互作用的影响,从而免疫细胞可以诱导肿瘤细胞死亡,肿瘤细胞可以抑制免疫细胞。利用模型中时标的分离,我们使用匹配渐近方法推导出完整模型的一个新的二维长时标近似,该近似不同于Kuznetsov等人(1994)引入的准稳态近似,但对完整模型的数值解进行了验证。通过相平面分析,我们证明了我们的简化模型是可兴奋的,这是一个传统上与肿瘤免疫动力学无关的特征。通过系统的参数敏感性分析,我们证明了兴奋性产生复杂的分岔动力学模型。这些与各种临床观察到的现象一致,并表明兴奋性可能是肿瘤-免疫相互作用的基础。该模型展示了免疫编辑的三个阶段-消除,平衡和逃逸,通过不同肿瘤细胞浓度的稳定稳态。肿瘤细胞数量的这种异质性可能源于控制免疫系统特性及其对肿瘤反应的初始条件和/或模型参数的可变性。我们确定了不同的生物物理参数目标,可以用免疫治疗来控制肿瘤的大小,我们发现,患者之间的首选策略可能会有所不同,这取决于他们的免疫系统的强度,由相关模型参数的患者特异性值确定。
英文摘要:
We study a five-compartment mathematical model originally proposed by Kuznetsov et al. (1994) to investigate the effect of nonlinear interactions between tumour and immune cells in the tumour microenvironment, whereby immune cells may induce tumour cell death, and tumour cells may inactivate immune cells. Exploiting a separation of timescales in the model, we use the method of matched asymptotics to derive a new two-dimensional, long-timescale, approximation of the full model, which differs from the quasi-steady-state approximation introduced by Kuznetsov et al. (1994), but is validated against numerical solutions of the full model. Through a phase-plane analysis, we show that our reduced model is excitable, a feature not traditionally associated with tumour-immune dynamics. Through a systematic parameter sensitivity analysis, we demonstrate that excitability generates complex bifurcating dynamics in the model. These are consistent with a variety of clinically observed phenomena, and suggest that excitability may underpin tumour-immune interactions. The model exhibits the three stages of immunoediting - elimination, equilibrium, and escape, via stable steady states with different tumour cell concentrations. Such heterogeneity in tumour cell numbers can stem from variability in initial conditions and/or model parameters that control the properties of the immune system and its response to the tumour. We identify different biophysical parameter targets that could be manipulated with immunotherapy in order to control tumour size, and we find that preferred strategies may differ between patients depending on the strength of their immune systems, as determined by patient-specific values of associated model parameters.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。